GRDN Stock Analysis: Buy, Sell, or Hold?
GRDN - Guardian Pharmacy Services, Inc.
$37.62
-0.04 (-0.11%)
▼
5d:
+3.07%
30d:
+10.52%
90d:
+24.32%
BUY
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 11, 2026
Get Alerted When GRDN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: GRDN shows positive signals but monitor for confirmation. Market pricing in 0.2% decline. Moderate conviction.
💡 BUY OPPORTUNITY: GRDN shows positive signals but monitor for confirmation. Market pricing in 0.2% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$48.09
Based on 7.3% avg growth
INTRINSIC VALUE TODAY
$29.86
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: GRDN is currently trading at $37.62, which is considered extended relative to its 30-day fair value range of $32.67 to $36.14. The stock's valuation (Forward PE: 27.8) is in line with its historical norms (27.9). Remarkably, the market is currently pricing in an annual earnings decline of 0.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, GRDN is in a strong uptrend. The price is approaching resistance at $38.34. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: GRDN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (24th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GRDN is in a strong uptrend. The price is approaching resistance at $38.34. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: GRDN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (24th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$32.67 -
$36.14
Company Quality Score
63/100
(BUY)
Options IV Signal
24th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
65.4%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 24th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($39.60)
Fair Price Analysis
30-Day Fair Range
$32.67 -
$36.14
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$3.17
(8.4%)
Support & Resistance Levels
Support Level
$31.92
Resistance Level
$38.34
Current Trend
Strong Uptrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
27.78
Wall Street Target
$39.60
(+5.3%)
Revenue Growth (YoY)
17.4%
Profit Margin
3.4%
Valuation Discount vs History
-0.2% cheaper
PE vs Historical
27.8 vs 27.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.2%
(market-implied from PE analysis)
1-Year Target
$37.54
(0%)
2-Year Target
$37.47
(0%)
3-Year Target
$37.39
(-1%)
3-Yr Target (if PE normalizes)
(PE: 28→28)
$37.55
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 27.8, Growth: 10.6%)
$50.92
(+35%)
Base:
(SPY PE: 22.4, Growth: 10.6%)
$40.96
(+9%)
Bear:
(PE: 19.0, Growth: 10.6%)
$34.82
(-7%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (46x PE), but valuation improves significantly next year (28x PE) as earnings recover.
Trailing PE: 45.67 | Current EPS (TTM): $0.78
Bull Case
$68.19
(+83%)
Analyst growth 74.0%, PE expands to 50.2
Base Case
$61.99
(+66%)
Market implied 74.0%, PE stable at 45.7
Bear Case
$24.22
(-35%)
Severe decline -20.0%, PE contracts to 38.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 27.8 to 27.9
Stabilization Target:
$37.78
(+0.4%)
PE Expansion Potential:
+0.4%
Share & Embed Analysis
Last updated: April 02, 2026 4:20 AM ET
Data refreshes hourly during market hours. Next update: 5:20 AM
Data refreshes hourly during market hours. Next update: 5:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GRDN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$261 | 58 HOLD |
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$543 | 58 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$143 | 53 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 47 HOLD |
|
ASTH
Astrana Health Inc |
STRONG BUY
12 analysts |
$36 | 65 BUY |
Advanced GRDN Option Strategies
Professional options setups generated by AI based on today's GRDN price and gamma walls.
